7.70
+0.42
+(5.77%)
At close: 4:00:02 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,344,123.00
3,875,907.00
2,451,608.00
1,923,719.00
1,443,782.00
Cost of Revenue
2,677,247.00
2,440,561.00
1,571,904.00
1,236,784.00
914,354.00
Gross Profit
1,666,876.00
1,435,346.00
879,704.00
686,935.00
529,428.00
Operating Expense
968,853.00
889,615.00
636,584.00
559,003.00
406,417.00
Operating Income
698,023.00
545,731.00
243,120.00
127,932.00
123,011.00
Net Non Operating Interest Income Expense
-670,859.00
-606,504.00
-208,854.00
-98,400.00
-59,829.00
Other Income Expense
-50,409.00
-63,401.00
-81,713.00
-32,658.00
-76,404.00
Pretax Income
-23,245.00
-124,174.00
-47,447.00
-3,126.00
-13,222.00
Tax Provision
96,123.00
90,170.00
29,383.00
19,897.00
-7,844.00
Net Income Common Stockholders
-123,004.00
-253,921.00
-85,606.00
-26,473.00
-7,104.00
Diluted NI Available to Com Stockholders
-123,004.00
-253,921.00
-85,606.00
-26,473.00
-7,104.00
Basic EPS
-1.66
-3.44
-1.16
-0.36
-0.10
Diluted EPS
-1.66
-3.44
-1.16
-0.36
-0.10
Basic Average Shares
73,917.58
73,917.58
73,917.58
73,917.58
73,917.58
Diluted Average Shares
73,917.58
73,917.58
73,917.58
73,917.58
73,917.58
Total Operating Income as Reported
723,938.00
560,340.00
254,587.00
108,142.00
118,421.00
Total Expenses
3,646,100.00
3,330,176.00
2,208,488.00
1,795,787.00
1,320,771.00
Net Income from Continuing & Discontinued Operation
-123,004.00
-253,921.00
-85,606.00
-26,473.00
-7,104.00
Normalized Income
-33,477.46
-181,742.40
-17,854.80
3,946.34
51,518.16
Interest Income
12,461.00
16,963.00
6,884.00
1,748.00
2,088.00
Interest Expense
595,576.00
535,723.00
208,497.00
95,877.00
56,881.00
Net Interest Income
-670,859.00
-606,504.00
-208,854.00
-98,400.00
-59,829.00
EBIT
572,331.00
411,549.00
161,050.00
92,751.00
43,659.00
EBITDA
795,719.00
647,299.00
299,141.00
170,146.00
108,358.00
Reconciled Cost of Revenue
2,677,247.00
2,303,677.00
1,477,037.00
1,179,693.00
866,661.00
Reconciled Depreciation
223,388.00
235,750.00
138,091.00
77,395.00
64,699.00
Net Income from Continuing Operation Net Minority Interest
-123,004.00
-253,921.00
-85,606.00
-26,473.00
-7,104.00
Total Unusual Items Excluding Goodwill
-126,988.00
-102,381.00
-96,101.00
-43,148.00
-83,152.00
Total Unusual Items
-126,988.00
-102,381.00
-96,101.00
-43,148.00
-83,152.00
Normalized EBITDA
922,707.00
749,680.00
395,242.00
213,294.00
191,510.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-37,461.46
-30,202.40
-28,349.80
-12,728.66
-24,529.84
12/31/2020 - 3/22/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARDT Ardent Health Partners, Inc.
14.05
-12.46%
PNTG The Pennant Group, Inc.
26.51
+1.07%
CCRN Cross Country Healthcare, Inc.
18.16
-0.16%
LFST LifeStance Health Group, Inc.
7.76
+0.39%
JRSS JRSIS Health Care Corporation
0.1670
0.00%
TOIIW The Oncology Institute, Inc.
0.0116
+10.48%
MSGP MedSmart Group Inc.
0.0001
0.00%
PIIIW P3 Health Partners Inc.
0.0137
+22.32%
PTLKF PT Lippo Karawaci Tbk
0.0090
0.00%
IONM Assure Holdings Corp.
0.0190
-40.63%